Tuberculosis patients living with HIV receiving antiretroviral therapy in Trinidad and Tobago

Trinidad and Tobago: Tuberculosis patients living with HIV receiving antiretroviral therapy was 12 patients in 2021. ▼ Falling

Latest (2021)
12 patients
Change on year
down 60.0%
World rank
106th
of 183 countries
All-time high
40 patients
in 2014
All-time low
6 patients
in 2009
Years of data
19
2003–2021

Tuberculosis patients living with HIV receiving antiretroviral therapy in Trinidad and Tobago, 2003–2021

102030402003201220212003: 18 patients2004: 14 patients2005: 15 patients2006: 36 patients2007: 17 patients2008: 36 patients2009: 6 patients2010: 20 patients2011: 16 patients2012: 24 patients2013: 30 patients2014: 40 patients2015: 16 patients2016: 32 patients2017: 8 patients2018: 15 patients2019: 12 patients2020: 30 patients2021: 12 patients

Source: Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Measured in patients.

Analysis

In 2021, tuberculosis patients living with hiv receiving antiretroviral therapy in Trinidad and Tobago stood at 12 patients.

That represents a change of down 60.0% on the previous year and down 25.0% over ten years.

Over the whole period, tuberculosis patients living with hiv receiving antiretroviral therapy in Trinidad and Tobago peaked at 40 patients in 2014 and was at its lowest, 6 patients, in 2009.

That places Trinidad and Tobago 106th out of 183 countries with data for 2021, putting it in the middle of the range.

The long-run direction has been consistently falling across the 19 years of available data.

Tuberculosis patients living with HIV receiving antiretroviral therapy in Trinidad and Tobago, year by year

Annual values for Tuberculosis patients living with HIV receiving antiretroviral therapy in Trinidad and Tobago, 2003 to 2021.
Year patients Change
2003 18 patients
2004 14 patients -22.2%
2005 15 patients +7.1%
2006 36 patients +140.0%
2007 17 patients -52.8%
2008 36 patients +111.8%
2009 6 patients -83.3%
2010 20 patients +233.3%
2011 16 patients -20.0%
2012 24 patients +50.0%
2013 30 patients +25.0%
2014 40 patients +33.3%
2015 16 patients -60.0%
2016 32 patients +100.0%
2017 8 patients -75.0%
2018 15 patients +87.5%
2019 12 patients -20.0%
2020 30 patients +150.0%
2021 12 patients -60.0%

Trinidad and Tobago compared with similar countries

  • Trinidad and Tobago's 12 patients is above the median for high income countries, which is 1 patients, 12.0× the median. (50 countries reporting)
  • Trinidad and Tobago's 12 patients is below the median for Latin America & Caribbean, which is 38 patients, 32% of the median. (37 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 20.29 patients 6 patients 36 patients 7
2010s 21.3 patients 8 patients 40 patients 10
2020s 21 patients 12 patients 30 patients 2

Countries ranked near Trinidad and Tobago

  1. 105 Bahamas 14 patients compare
  2. 106 Egypt 12 patients compare
  3. 106 Mauritius 12 patients compare
  4. 106 Sao Tome and Principe 12 patients compare
  5. 106 Suriname 12 patients compare

See the full ranking of 183 places →

More health data for Trinidad and Tobago

All data for Trinidad and Tobago →

Frequently asked questions

What is tuberculosis patients living with hiv receiving antiretroviral therapy in Trinidad and Tobago?
Tuberculosis patients living with hiv receiving antiretroviral therapy in Trinidad and Tobago was 12 patients in 2021, according to Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data.
What is the highest tuberculosis patients living with hiv receiving antiretroviral therapy recorded in Trinidad and Tobago?
The highest recorded value was 40 patients in 2014.
What is the lowest tuberculosis patients living with hiv receiving antiretroviral therapy recorded in Trinidad and Tobago?
The lowest recorded value was 6 patients in 2009.
How does Trinidad and Tobago rank for tuberculosis patients living with hiv receiving antiretroviral therapy?
Trinidad and Tobago ranks 106th out of 183 countries with data for 2021.
Is tuberculosis patients living with hiv receiving antiretroviral therapy rising or falling in Trinidad and Tobago?
Over the last ten years it is down 25.0%. The long-run trend across the full record is falling.
Where does this Trinidad and Tobago data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as part of Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 19 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Tuberculosis patients living with HIV receiving antiretroviral therapy in Trinidad and Tobago. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 13 September 2026, from https://health.statizoid.com/stat/tb-patients-living-with-hiv-receiving-art/trinidad-and-tobago/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/tb-patients-living-with-hiv-receiving-art/trinidad-and-tobago/">Tuberculosis patients living with HIV receiving antiretroviral therapy in Trinidad and Tobago</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.